Ticagrelor induced systemic inflammatory response syndrome

BACKGROUND: Ticagrelor is a reversible and direct-acting oral antagonist of the adenosine diphosphate receptor P2Y12. Possible adenosine-mediated effects of ticagrelor on inflammation are complex and incompletely understood. To our knowledge, ticagrelor-induced systemic inflammatory response syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Krisai, Philipp, Haschke, Manuel, Buser, Peter T., Mueller, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217217/
https://www.ncbi.nlm.nih.gov/pubmed/28056791
http://dx.doi.org/10.1186/s12872-016-0443-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217217/
https://www.ncbi.nlm.nih.gov/pubmed/28056791
http://dx.doi.org/10.1186/s12872-016-0443-8

Ejemplares similares